NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Immucell Corp Share Price Chart

O H L

Immucell Corp Performance Overview

Days Range
$9.69Low
$9.90High

Markets Today

Previous Close$9.98
Open$9.69
Volume32,936
Day's Range$9.69 - $9.90
52W Range$4.52 - $12.10
Market Cap$87.28 M

Historical Performance

1M Returns+2.25
3M Returns+5.16
6M Returns+65.23
1Y Returns+76.33
5Y Returns+2.46
10Y Returns+27.46

Immucell Corp Fundamentals

Market Cap$87.28 M
Dividend yield0.00
PE Ratio114.57
PEG RatioN/A
Revenue$27.64 M
ROE TTM-0.04
EPS TTM$0.08
Quarterly Earnings Growth YOYN/A
PB Ratio2.78
EBITDA$4.38 M
Profit Margin-3.76
Market Cap$87.28 M
Dividend yield0.00
PE Ratio114.57
PEG RatioN/A
Revenue$27.64 M
ROE TTM-0.04
EPS TTM$0.08
Quarterly Earnings Growth YOYN/A
PB Ratio2.78
EBITDA$4.38 M
Profit Margin-3.76

Immucell Corp Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$8.07 M$6.44 M$5.51 M$7.63 M$10.36 M$7.19 M
Gross Profit +$3.35 M$2.82 M$2.36 M$2.91 M$4.66 M$2.44 M
Operating Income $1.12 M$569.56 K$20.07 K-$57.96 K$1.97 M$1.93 M
EBITDA $1.79 M$1.24 M$699.16 K$648.36 K$2.50 M$2.41 M
Interest Expense $0-$124.80 K$0$0$0-$95.67 K
Depreciation $675.97 K$668.23 K$679.09 K$706.32 K$528.29 K$470.62 K
Income Before Tax $1.45 M$503.78 K-$135.29 K-$2.85 M$1.95 M$1.88 M
Income Tax Expense $1.90 K$1.90 K$4.46 K$3.31 K$12.52 K$45.95 K
Net Income +$1.45 M$501.88 K-$139.75 K-$2.85 M$1.94 M$1.83 M
Net Profit Margin 17.94%7.79%-2.54%-37.36%18.75%25.53%

Immucell Corp Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $904.59 K$910.56 K$910.56 K$910.56 K$910.56 K$910.56 K
Reserve & Surplus -$12.72 M-$12.21 M-$12.35 M-$15.20 M-$13.26 M-$11.43 M
Non-Current Liabilities $12.76 M$12.41 M$11.93 M$11.50 M$11.06 M$10.82 M
Current Liabilities $3.87 M$4.45 M$4.00 M$3.98 M$3.91 M$4.44 M
Total Liabilities $16.63 M$16.85 M$15.93 M$15.48 M$14.97 M$15.26 M
Fixed Assets $25.03 M$24.89 M$24.35 M$21.07 M$20.78 M$21.03 M
Current Assets $15.92 M$17.14 M$16.83 M$16.94 M$18.86 M$21.08 M
Total Assets $45.62 M$46.72 M$45.73 M$42.53 M$44.11 M$46.63 M

Immucell Corp Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income $1.45 M$501.88 K-$139.75 K-$2.85 M$1.94 M$1.83 M
Operating Cash Flow $1.57 M$1.60 M-$1.18 M$482.54 K$3.57 M$3.02 M
Investing Cash Flow -$329.05 K-$125.93 K-$592.02 K-$167.31 K-$167.23 K-$733.94 K
Financing Cash Flow -$403.65 K-$76.45 K-$337.69 K-$394.60 K-$400.00 K-$237.56 K
Change in Cash $841.14 K$1.40 M-$2.11 M-$79.37 K$3.01 M$2.05 M

Immucell Corp Return Calculator

The Immucell Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$9,856
Invested Amount$10,000
Est. Returns$-144
Invest in USA Stock Today

About Immucell Corp

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

FAQs

Immucell Corp (ICCC) share price as of September 18, 2026 is $9.60. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Immucell Corp (ICCC) Share by opening an international trading account with Angel One.
Purchasing Immucell Corp (ICCC) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Immucell Corp (ICCC) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Immucell Corp (ICCC) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Immucell Corp on September 18, 2026, is $87.28 M.
Immucell Corp operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Immucell Corp (ICCC) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91